Advances in treatment of immune-related adverse reactions and hyperprogressive diseases associated with antitumor  immunotherapy with PD-1/PD-L1 monoclonal antibody drugs
WANG Pengyan, LIN Ziyou, ZHU Kai, ZHANG Xiaolei
Chinese Journal of Pharmacology and Toxicology . 2024, (1): 56 .  DOI: 10.3867/j.issn.1000-3002.2024.01.007